Molecular basis of non-alcoholic fatty liver disease and metabolic syndrome in a subset of South Asians

[1] Cho N(2018)IDF Diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045 Diabetes Res Clin Pract 138 271-281

[2] Shaw J(2017)Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review BMC Public Health 17 101-175

[3] Karuranga S(2008)Prevalence of metabolic syndrome in Pakistan Metab Syndr Relat Disord 6 171-SS5

[4] Huang Y(2018)Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome Can J Diabetes 42 S10-43

[5] da Rocha FJ(2010)The distinction of metabolically ‘healthy’from ‘unhealthy’obese individuals Curr Opin Lipidol 21 38-90

[6] Ohlrogge A(2011)Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey BMC Public Health 11 754-4919

[7] Ranasinghe P(2019)The prevalence of metabolically healthy and unhealthy obesity according to different criteria Obes Facts 12 78-469

[8] Mathangasinghe Y(2009)Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor Endocrinology. 150 4911-177

[9] Jayawardena R(2015)The evaluation of nesfatin-1 levels in patients with OSAS associated with metabolic syndrome J Endocrinol Investig 38 463-405

[10] Hills A(2014)Regulatory neuropeptides (ghrelin, obestatin and nesfatin-1) levels in serum and reproductive tissues of female and male rats with fructose-induced metabolic syndrome Neuropeptides. 48 167-117

[1] Cho N(2018)IDF Diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045 Diabetes Res Clin Pract 138 271-281

[2] Shaw J(2017)Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review BMC Public Health 17 101-175

[3] Karuranga S(2008)Prevalence of metabolic syndrome in Pakistan Metab Syndr Relat Disord 6 171-SS5

[4] Huang Y(2018)Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome Can J Diabetes 42 S10-43

[5] da Rocha FJ(2010)The distinction of metabolically ‘healthy’from ‘unhealthy’obese individuals Curr Opin Lipidol 21 38-90

[6] Ohlrogge A(2011)Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey BMC Public Health 11 754-4919

[7] Ranasinghe P(2019)The prevalence of metabolically healthy and unhealthy obesity according to different criteria Obes Facts 12 78-469

[8] Mathangasinghe Y(2009)Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor Endocrinology. 150 4911-177

[9] Jayawardena R(2015)The evaluation of nesfatin-1 levels in patients with OSAS associated with metabolic syndrome J Endocrinol Investig 38 463-405

[10] Hills A(2014)Regulatory neuropeptides (ghrelin, obestatin and nesfatin-1) levels in serum and reproductive tissues of female and male rats with fructose-induced metabolic syndrome Neuropeptides. 48 167-117